Generics BRIC (Brazil, Russia, India, China) Industry Guide_2017

Generics BRIC (Brazil, Russia, India, China) Industry Guide_2017 Cover

Single Licence: $995

Buy Now
customer(s) bought this report

Shopping on is Safe and Secure. GUARANTEED!
All information is encrypted and handled by

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at or call us at +61 (02) 8011 3208
# Pages
Single User
Site License
Pharmaceuticals and Healthcare

Generics BRIC (Brazil, Russia, India, China) Industry Guide_2017


The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the BRIC generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies. – Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $87.2 billion in 2016. China was the fastest growing country with a CAGR of 15.5% over the 2012-16 period. – Within the generics industry, China is the leading country among the BRIC nations with market revenues of $63.1 billion in 2016. This was followed by India, Russia and Brazil with a value of $13.3, $7.0, and $3.9 billion, respectively. – China is expected to lead the generics industry in the BRIC nations with a value of $104.9 billion in 2021, followed by India, Russia, Brazil with expected values of $25.8, $9.6 and $4.1 billion, respectively.


– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the BRIC generics market – Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC generics market – Leading company profiles reveal details of key generics market players’ BRIC operations and financial performance – Add weight to presentations and pitches by understanding the future growth prospects of the BRIC generics market with five year forecasts by both value and volume – Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country

Reasons to buy

– What was the size of the BRIC generics market by value in 2016? – What will be the size of the BRIC generics market in 2021? – What factors are affecting the strength of competition in the BRIC generics market? – How has the market performed over the last five years? – Who are the top competitors in the BRIC generics market? 

Request more information (Table of Contents, List of table, List of Figures) by using the form below:

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $995

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.